Autonomix Medical, Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Preliminary Proxy Statement

Registration statement under Securities Act of 1933

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Other Events

Registration statement under Securities Act of 1933

Entry into a Material Definitive Agreement

Other Events

Material Modifications to Rights of Security Holders

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Regulation FD Disclosure

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Submission of Matters to a Vote of Security Holders

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Amended Initial Registration Statement

Preliminary Proxy Statement

Letter from the SEC

Other Events

Entry into a Material Definitive Agreement

Prospectus Supplement for Primary Offering

Registration (IPO) statement under Securities Act of 1933

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Prospectus Supplement for Primary Offering

Entry into a Material Definitive Agreement

Annual report pursuant to Section 13 or 15(d)

Regulation FD Disclosure

Correspondence with the SEC

Letter from the SEC

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Entry into a Material Definitive Agreement

Correspondence with the SEC

Correspondence with the SEC

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

8.01

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Annual report pursuant to Section 13 or 15(d) (amendment)

Draft registration statement (confidential submission)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Offering circular under Regulation A (Rule 253(g)(2))

No description available

No description available

Offering circular under Regulation A (Rule 253(g)(2))

Semiannual Report or Special Financial Report Pursuant to Regulation A

Offering circular under Regulation A (Rule 253(g)(2))

No description available

Regulation A Offering Statement (amendment)

Correspondence with the SEC

Regulation A Offering Statement (amendment)

Smith Trent N.

Bisson Lori

Hauser Bradley

KLEMP WALTER V

Smith Trent N.

Hauser Bradley

Capelli Christopher

KLEMP WALTER V

Bisson Lori

Robins David Andrew

Bisson Lori

KLEMP WALTER V

Smith Trent N.

BioStar Ventures III, L.P.